SHMT2
Basic information
Region (hg38): 12:57229573-57234935
Previous symbols: [ "SHMT" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (Strong), mode of inheritance: AR
- neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities | AR | Cardiovascular | Among other findings, the condition can include progressive cardiomyopathy, and awareness may allow early diagnosis and management; Cardiac transplant has been described | Cardiovascular; Musculoskeletal; Neurologic | 33015733 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (48 variants)
- not_provided (22 variants)
- Neurodevelopmental_disorder_with_cardiomyopathy,_spasticity,_and_brain_abnormalities (14 variants)
- SHMT2-related_disorder (4 variants)
- Neurodevelopmental_disorder (2 variants)
- not_specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHMT2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005412.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | |||||
| missense | 60 | 68 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 0 | 4 | 64 | 8 | 2 |
Highest pathogenic variant AF is 0.0000034203704
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SHMT2 | protein_coding | protein_coding | ENST00000328923 | 12 | 5609 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 7.82e-8 | 0.977 | 125711 | 0 | 37 | 125748 | 0.000147 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.52 | 234 | 309 | 0.756 | 0.0000194 | 3234 |
| Missense in Polyphen | 88 | 137.89 | 0.63817 | 1442 | ||
| Synonymous | -0.677 | 131 | 122 | 1.08 | 0.00000704 | 1063 |
| Loss of Function | 2.16 | 16 | 28.4 | 0.563 | 0.00000186 | 276 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000359 | 0.000359 |
| Ashkenazi Jewish | 0.0000996 | 0.0000992 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000159 | 0.000158 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000196 | 0.000196 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the cleavage of serine to glycine accompanied with the production of 5,10-methylenetetrahydrofolate, an essential intermediate for purine biosynthesis (PubMed:24075985, PubMed:29364879, PubMed:25619277). Serine provides the major source of folate one-carbon in cells by catalyzing the transfer of one carbon from serine to tetrahydrofolate (PubMed:25619277). Contributes to the de novo mitochondrial thymidylate biosynthesis pathway via its role in glycine and tetrahydrofolate metabolism: thymidylate biosynthesis is required to prevent uracil accumulation in mtDNA (PubMed:21876188). Also required for mitochondrial translation by producing 5,10- methylenetetrahydrofolate; 5,10-methylenetetrahydrofolate providing methyl donors to produce the taurinomethyluridine base at the wobble position of some mitochondrial tRNAs (PubMed:29452640, PubMed:29364879). Associates with mitochondrial DNA (PubMed:18063578). In addition to its role in mitochondria, also plays a role in the deubiquitination of target proteins as component of the BRISC complex: required for IFNAR1 deubiquitination by the BRISC complex (PubMed:24075985). {ECO:0000269|PubMed:18063578, ECO:0000269|PubMed:21876188, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25619277, ECO:0000269|PubMed:29364879, ECO:0000269|PubMed:29452640}.;
- Pathway
- One carbon pool by folate - Homo sapiens (human);Glycine, serine and threonine metabolism - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;sarcosine oncometabolite pathway ;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Glycine Metabolism;Vitamin B12 Metabolism;Folate Metabolism;One Carbon Metabolism;Trans-sulfuration and one carbon metabolism;One carbon metabolism and related pathways;Pathways in clear cell renal cell carcinoma;folate polyglutamylation;Folate metabolism;glycine/serine biosynthesis;Glycine Serine metabolism;Metabolism;Lysine degradation;folate transformations I;glycine betaine degradation;Metabolism of folate and pterines;dTMP <i>de novo</i> biosynthesis (mitochondrial);Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;superpathway of choline degradation to L-serine;Lysine metabolism;Vitamin B9 (folate) metabolism;serine and glycine biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.395
Intolerance Scores
- loftool
- 0.822
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.26
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.923
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Shmt2
- Phenotype
- embryo phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- regulation of oxidative phosphorylation;glycine metabolic process;L-serine metabolic process;L-serine biosynthetic process;L-serine catabolic process;one-carbon metabolic process;positive regulation of cell population proliferation;glycine biosynthetic process from serine;response to type I interferon;tetrahydrofolate interconversion;tetrahydrofolate metabolic process;folic acid metabolic process;protein tetramerization;protein homotetramerization;regulation of mitochondrial translation;protein K63-linked deubiquitination;regulation of aerobic respiration;cellular response to tetrahydrofolate
- Cellular component
- nucleus;cytoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial intermembrane space;mitochondrial matrix;microtubule cytoskeleton;mitochondrial nucleoid;extracellular exosome;BRISC complex
- Molecular function
- chromatin binding;glycine hydroxymethyltransferase activity;protein binding;zinc ion binding;L-allo-threonine aldolase activity;amino acid binding;pyridoxal phosphate binding;identical protein binding;cobalt ion binding;serine binding